Krka, d. d. (LJSE:KRKG)

Slovenia flag Slovenia · Delayed Price · Currency is EUR
230.00
-2.00 (-0.86%)
At close: Mar 6, 2026
36.90%
Market Cap 7.01B
Revenue (ttm) 2.01B
Net Income (ttm) 398.80M
Shares Out 30.46M
EPS (ttm) 13.02
PE Ratio 17.66
Forward PE 17.82
Dividend 8.25 (3.59%)
Ex-Dividend Date Jul 22, 2025
Volume 7,888
Average Volume 5,310
Open 230.00
Previous Close 232.00
Day's Range 225.00 - 233.00
52-Week Range 150.50 - 251.00
Beta 0.48
RSI 47.63
Earnings Date Mar 12, 2026

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 13,107
Stock Exchange Ljubljana Stock Exchange
Ticker Symbol KRKG
Full Company Profile

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial Statements

News

There is no news available yet.